---
figid: PMC2266858__6604213f1
figlink: /pmc/articles/PMC2266858/figure/fig1/
number: Figure 1
caption: Interaction between TKIs and BCRP. An active PI3K–Akt pathway is apparently
  important for BCRP expression and localisation in the plasma membrane. (A) Stimulation
  of this pathway with EGF, for example, will phosphorylate Akt, leading to BCRP localisation
  to the plasma membrane. (B) (I) BCRP can actively efflux TKIs, thus inducing resistance
  to these drugs. However, BCRP-mediated TKIs resistance might be abrogated by TKIs
  inhibition of the PI3K–Akt pathway, which can lead to (II) BCRP relocalisation to
  the intracellular compartment and/or (III) decreased BCRP expression.
pmcid: PMC2266858
papertitle: 'Drug transporters: recent advances concerning BCRP and tyrosine kinase
  inhibitors.'
reftext: C Lemos, et al. Br J Cancer. 2008 Mar 11;98(5):857-862.
pmc_ranked_result_index: '79500'
pathway_score: 0.8049387
filename: 6604213f1.jpg
figtitle: Interaction between TKIs and BCRP
year: '2008'
organisms: Homo sapiens
ndex: c3e1c8ec-de9c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2266858__6604213f1.html
  '@type': Dataset
  description: Interaction between TKIs and BCRP. An active PI3K–Akt pathway is apparently
    important for BCRP expression and localisation in the plasma membrane. (A) Stimulation
    of this pathway with EGF, for example, will phosphorylate Akt, leading to BCRP
    localisation to the plasma membrane. (B) (I) BCRP can actively efflux TKIs, thus
    inducing resistance to these drugs. However, BCRP-mediated TKIs resistance might
    be abrogated by TKIs inhibition of the PI3K–Akt pathway, which can lead to (II)
    BCRP relocalisation to the intracellular compartment and/or (III) decreased BCRP
    expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - PIK3CB
  - PIK3R6
  - EGF
  - AKT1
  - PIK3R5
  - ABCG2
  - PIK3R3
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - AKT3
  - AKT2
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: BCRP
  symbol: BCRP
  source: hgnc_alias_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals: []
diseases: []
---
